Japan Society of Gynecologic Oncology guidelines 2015 for the treatment of vulvar cancer and vaginal cancer Toshiaki SaitoTsutomu TabataHidetaka Katabuchi Special Article Open access 20 November 2017 Pages: 201 - 234
Histological transformation after acquired resistance to epidermal growth factor tyrosine kinase inhibitors Yi ShaoDian-Sheng Zhong Review Article 07 November 2017 Pages: 235 - 242
Esophageal squamous cell neoplasia is an independent negative prognostic factor for head and neck cancer patients Yasuhiko HamadaToshiro MizunoNaoyuki Katayama Original Article 24 October 2017 Pages: 243 - 248
Associations between clinical data and computed tomography features in patients with epidermal growth factor receptor mutations in lung adenocarcinoma Yiyuan CaoHaibo XuSufang Tian Original Article Open access 07 October 2017 Pages: 249 - 257
Monitoring the estimated glomerular filtration rate (eGFR) in patients with small-cell lung cancer during chemotherapy: equations based on serum creatinine or cystatin C? Xue TianXinxing ZhangYouling Gong Original Article 04 November 2017 Pages: 258 - 265
A survival analysis using physique-adjusted tumor size of non-small cell lung cancer Naoki OzekiTakayuki FukuiKohei Yokoi Original Article 29 November 2017 Pages: 266 - 274
First-line bolus 5-fluorouracil plus leucovorin for peritoneally disseminated gastric cancer with massive ascites or inadequate oral intake Hiroki HaraShigenori KadowakiKensei Yamaguchi Original Article 16 October 2017 Pages: 275 - 280
MMC/UFT/LV in refractory colorectal cancer: phase II study and analysis of predictive variables of progression Chiara BaratelliMarco TampelliniGiorgio Vittorio Scagliotti Original Article 27 September 2017 Pages: 281 - 286
Selecting patients for hyperthermia combined with preoperative chemoradiotherapy for locally advanced rectal cancer Sang-Won KimJi Woon YeaMin Kyu Kang Original Article 13 November 2017 Pages: 287 - 297
Repeat cytoreduction and hyperthermic intraperitoneal chemotherapy for recurrent peritoneal carcinomatosis of appendiceal origin Toshiyuki KitaiKenya Yamanaka Original Article 27 November 2017 Pages: 298 - 304
The detection of sentinel lymph nodes in laparoscopic surgery can eliminate systemic lymphadenectomy for patients with early stage endometrial cancer Tomohito TanakaYoshito TeraiMasahide Ohmichi Original Article Open access 02 November 2017 Pages: 305 - 313
Radiotherapy for vaginal cancer: a multi-institutional survey study of the Japanese Radiation Oncology Study Group Hitoshi IkushimaMasaru WakatsukiTakafumi Toita Original Article 30 October 2017 Pages: 314 - 320
Combined detection of Twist1, Snail1 and squamous cell carcinoma antigen for the prognostic evaluation of invasion and metastasis in cervical squamous cell carcinoma Huilun YangHaiyang HuZongfeng Zhang Original Article 03 November 2017 Pages: 321 - 328
Carcinosarcoma of the ovary compared to ovarian high-grade serous carcinoma: impact of optimal cytoreduction and standard adjuvant treatment Ibrahim YalcinMehmet Mutlu MeydanliAli Ayhan Original Article 16 November 2017 Pages: 329 - 337
Significance of sarcopenia as a prognostic factor for metastatic urothelial carcinoma patients treated with systemic chemotherapy Hideyuki AbeKohei TakeiTakao Kamai Original Article 02 November 2017 Pages: 338 - 346
Impact of a robotic surgical system on treatment choice for men with clinically organ-confined prostate cancer Takashi KobayashiKent KanaoOsamu Ogawa Original Article 11 November 2017 Pages: 347 - 352
Acute toxicity of image-guided hypofractionated proton therapy for localized prostate cancer Koichiro NakajimaHiromitsu IwataJun-etsu Mizoe Original Article 02 November 2017 Pages: 353 - 360
Significance of prostate-specific antigen kinetics after three-dimensional conformal radiotherapy with androgen deprivation therapy in patients with localized prostate cancer Wataru FukuokayaSangji KimKoichiro Akakura Original Article 18 November 2017 Pages: 361 - 367
Neutrophil-to-lymphocyte ratio after pazopanib treatment predicts response in patients with advanced soft-tissue sarcoma Hiroshi KobayashiTomotake OkumaSakae Tanaka Original Article 31 October 2017 Pages: 368 - 374
Retrospective analysis of first-line treatment for follicular lymphoma based on outcomes and medical economics Manaka MuneishiAyaka NakamuraYoshihiro Yakushijin Original Article 24 October 2017 Pages: 375 - 381
A double-blind randomized phase II dose-finding study of olanzapine 10 mg or 5 mg for the prophylaxis of emesis induced by highly emetogenic cisplatin-based chemotherapy Takako YanaiSatoru IwasaNoboru Yamamoto Original Article 16 October 2017 Pages: 382 - 388
Risk of fatigue in cancer patients receiving anti-EGFR monoclonal antibodies: results from a systematic review and meta-analysis of randomized controlled trial Jianhong ZhuWenxia ZhaoJianfang Li Original Article 27 November 2017 Pages: 389 - 399
Further augmentation of molecular responses with dasatinib therapy in chronic myeloid leukemia patients who gained major molecular response under imatinib Ahmet Emre Eskazan Letter to the Editor 13 November 2017 Pages: 400 - 401
Correction to: S-1 and irinotecan plus bevacizumab as second-line chemotherapy for patients with oxaliplatin-refractory metastatic colorectal cancer: a multicenter phase II study in Japan (KSCC1102) Yuji MiyamotoAkihito TsujiYoshihiko Maehara Correction 14 November 2017 Pages: 402 - 402
